The clinical evaluation of Vi-one chlorhexidine mouthrinse on plaque induced gingivitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201602231760N45

Enrollment

Registered

2016-03-05

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic gingivitis. Chronic gingivitis

Interventions

Intervention 1: Intervention groups: Patients are requested to use VI-ONE mouthrinse for 30 seconds (0.2%chlorhexidine type and alcohol free/ manufactured by Rojin Chemicals) twice a day, once in the

Treatment - Drugs

Intervention groups: Patients are requested to use VI-ONE mouthrinse for 30 seconds (0.2%chlorhexidine type and alcohol free/ manufactured by Rojin Chemicals) twice a day, once in the morning and on

Control groups: Methods such as the intervention group. The difference is that the patients mouthwash containing Chlorhexidine 0.2% (manufacturer: Pharmacy BEHSA) is given.

Eligibility

Sex/Gender

All

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the patient's age, 25 to 50 years; chronic gingivitis patients with moderate - severe associated with dental plaque; patients with the ability to cooperate and has a similar plaque index. Exclusion criteria: patients with a history of systemic diseases affecting the periodontal; smoking; patients with any periodontal treatment during the last 6 months; patients treated with antibiotics in the past month.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Plaque induced. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Plaque Index (PI), based on the Silness and Loe's method.;Plaque Index. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Plaque Index (PI) based on Silness and Loe's method.;Gingival index. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Gingival index (GI) based on the method of Loe and Silness.;Gingival bleeding index. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Gingival bleeding index (Bleeding Index (BI) (Bernet.	—

Measure

Time frame

Plaque induced. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Plaque Index (PI), based on the Silness and Loe's method.;Plaque Index. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Plaque Index (PI) based on Silness and Loe's method.;Gingival index. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Gingival index (GI) based on the method of Loe and Silness.;Gingival bleeding index. Timepoint: The first day of the study and two weeks after the start of the study. Method of measurement: Gingival bleeding index (Bleeding Index (BI) (Bernet.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzyeh Omidbakhsh

Dental College of Babol

marzyehomidbakhsh@yahoo.com+98 11 3229 1408

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 8, 2026